BD

Biotechnology Development Fund VI, L.P.

North America, California, United States, Palo Alto

Description

Biotechnology Development Fund IV, L.P. specializes in late venture investments. It seeks to invest in biotechnology, pharmaceutical,

Investor Profile

Biotechnology Development Fund VI, L.P. has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (33%)
  • Series D (33%)
  • Series Unknown (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Dietary Supplements
  • Health Care
  • Life Science
  • Nutrition
  • Biopharma
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biotechnology Development Fund VI, L.P. frequently co-invest with?

VI
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Toucan Capital
North America, Maryland, United States, Bethesda
Co-Investments: 1
Greenwich Associates
North America, Connecticut, United States, Stamford
Co-Investments: 1
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 1
Great Point Partners
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Muzinich & Co
North America, New York, United States, New York
Co-Investments: 1
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 1
Valley Ventures
North America, Arizona, United States, Phoenix
Co-Investments: 1
A. M. Pappas & Associates
North America, North Carolina, United States, Durham
Co-Investments: 1

What are some of recent deals done by Biotechnology Development Fund VI, L.P.?

Pepgen

Alameda, California, United States

Pepgen is a privately-held biopharmaceutical company that develops novel products for the treatment of autoimmune and viral disorders.

BiopharmaMedicalPharmaceutical
Series DAug 3, 2004
Amount Raised: $7,500,000
Forbes Medi-Tech

Kearny, New Jersey, United States

Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology.

BiotechnologyDietary SupplementsHealth CareLife ScienceNutrition
Series AJan 7, 2004
Amount Raised: $10,750,000
Copernicus Therapeutics

Cleveland, Ohio, United States

Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company

Biotechnology
Series UnknownJan 1, 1999
Amount Raised: $4,600,000